<p>Richard Gilstrap of Innovar Scientific Inc. in the U.S. will develop and test a device for rapid detection of freeze-damage in widely used adjuvant-type vaccines. This device could provide critical information needed for cold-chain optimization and effective immunization programs.</p>


Richard Gilstrap of Innovar Scientific Inc. in the U.S. will develop and test a device for rapid detection of freeze-damage in widely used adjuvant-type vaccines. This device could provide critical information needed for cold-chain optimization and effective immunization programs.